Corbus Pharmaceuticals Holdings (0SZI.L) Stock Price
$9.36 3.5%
to add to portfolio
AI Score

-
Alternative
4 -
Fundamental
2 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Corbus Pharmaceuticals Holdings, AI stock picks, stock alerts and much more.
0SZI.L AI Stock Analysis
AI stock analysis for 0SZI.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Corbus Pharmaceuticals Holdings (0SZI.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Corbus Pharmaceuticals Holdings (0SZI.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Corbus Pharmaceuticals Holdings (0SZI.L), currently trading at $9.36, will... Sign up to access price prediction.
About 0SZI.L

-
Corbus Pharmaceuticals Holdings, Inc.
-
Symbol
0SZI.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
114.7M
Similar Stocks
![]() |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$394.5 0.3% |
7 |
![]() |
Neurocrine Biosciences 0K6R.L |
$142.1 0.9% |
7 |
![]() |
Emergent BioSolutions Inc. 0IGA.L |
$8.23 1.5% |
5 |
![]() |
Abeona Therapeutics Inc. 0H7R.L |
$6.64 2.1% |
5 |
![]() |
Esperion Therapeutics 0IIM.L |
$2.8 2.9% |
6 |
News
0SZI.L Alternative Data
Web Traffic
Corbus Pharmaceuticals Holdings receives an estimated 4992 monthly visitors to corbuspharma.com, which is down by -1.3% over the last month.
-
Web Traffic
4992
-
Change from Previous Month
1.3%
-
3 Month Change
40.8%
-
YoY Change
40.8%
Twitter Followers
Corbus Pharmaceuticals Holdings has 5,698 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.
-
Twitter Followers
5698
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Facebook Engagement
Corbus Pharmaceuticals Holdings has engaged 78 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
78
-
Daily Change
5.4%
-
1 Month Change
1.3%
-
3 Month Change
18.2%
-
YoY Change
18.2%
Youtube Subscribers
Corbus Pharmaceuticals Holdings has 611 subscribers on its main Youtube channel, up by 0.2% over the last month.
-
Youtube Subscribers
611
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.3%
-
YoY Change
0.3%
Job Postings
Corbus Pharmaceuticals Holdings currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
-
YoY Change
100%
Reddit Mentions
Corbus Pharmaceuticals Holdings has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
16,593 are following Corbus Pharmaceuticals Holdings on LinkedIn, up by 0.4% over the last month.
-
LinkedIn Followers
16593
-
Daily Change
0.4%
-
1 Month Change
0.4%
-
3 Month Change
2%
-
YoY Change
2%
Business Outlook
According to employee reviews, the business outlook among employees at Corbus Pharmaceuticals Holdings is 33 out of 100 (bearish).
-
Business Outlook
33
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Corbus Pharmaceuticals Holdings has 51 employees, up by 2% over the last month.
-
LinkedIn Employees
51
-
Daily Change
2%
-
1 Month Change
2%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Corbus Pharmaceuticals Holdings was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0SZI.L Financials
0SZI.L Key Metrics
-
Total Revenue
$0
-
Net Income
-$9.5M
-
Earnings per Share
-$0.87
-
Free cash flow
-$10.9M
-
EBITDA
-$9.4M
-
EBITDA Ratio
0
-
Total Assets
$139.9M
0SZI.L 2-year Revenue & Income
0SZI.L 2-year Free Cash Flow
0SZI.L Technicals
0SZI.L SMA
0SZI.L RSI
FAQ
What's the current price of Corbus Pharmaceuticals Holdings (0SZI.L) Stock?
The price of an Corbus Pharmaceuticals Holdings (0SZI.L) share is $9.36.
What's the market cap of Corbus Pharmaceuticals Holdings?
The current market cap of Corbus Pharmaceuticals Holdings is 114.7M.
What are some stocks similar to Corbus Pharmaceuticals Holdings (0SZI.L) that investors often compare it to?
Corbus Pharmaceuticals Holdings (0SZI.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Corbus Pharmaceuticals Holdings' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Corbus Pharmaceuticals Holdings' stock price to be around $9.05 in 2026. Starting from the current price of $9.36, this represents a 3.3% change in price, indicating a neutral outlook for the stock.
How to buy Corbus Pharmaceuticals Holdings (0SZI.L) Stock?
Corbus Pharmaceuticals Holdings stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Corbus Pharmaceuticals Holdings shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.